nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.098	0.129	CbGbCtD
Methazolamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0723	0.095	CbGbCtD
Methazolamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0723	0.095	CbGbCtD
Methazolamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0601	0.0789	CbGbCtD
Methazolamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0601	0.0789	CbGbCtD
Methazolamide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0549	0.0722	CbGbCtD
Methazolamide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0549	0.0722	CbGbCtD
Methazolamide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.049	0.0643	CbGbCtD
Methazolamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0461	0.0606	CbGbCtD
Methazolamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0455	0.0598	CbGbCtD
Methazolamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0311	0.0409	CbGbCtD
Methazolamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0304	0.0399	CbGbCtD
Methazolamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0297	0.039	CbGbCtD
Methazolamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0265	0.0348	CbGbCtD
Methazolamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0155	0.0204	CbGbCtD
Methazolamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0147	0.0193	CbGbCtD
Methazolamide—Myopia—Montelukast—chronic obstructive pulmonary disease	0.0102	0.058	CcSEcCtD
Methazolamide—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.00576	0.0327	CcSEcCtD
Methazolamide—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.00576	0.0327	CcSEcCtD
Methazolamide—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.00544	0.0309	CcSEcCtD
Methazolamide—Appetite absent—Salbutamol—chronic obstructive pulmonary disease	0.00432	0.0245	CcSEcCtD
Methazolamide—Calculus of kidney—Formoterol—chronic obstructive pulmonary disease	0.00347	0.0197	CcSEcCtD
Methazolamide—Calculus of kidney—Arformoterol—chronic obstructive pulmonary disease	0.00347	0.0197	CcSEcCtD
Methazolamide—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.0161	CcSEcCtD
Methazolamide—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.00283	0.0161	CcSEcCtD
Methazolamide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.00281	0.016	CcSEcCtD
Methazolamide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.016	CcSEcCtD
Methazolamide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.0151	CcSEcCtD
Methazolamide—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00247	0.014	CcSEcCtD
Methazolamide—Melaena—Formoterol—chronic obstructive pulmonary disease	0.00222	0.0126	CcSEcCtD
Methazolamide—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.0126	CcSEcCtD
Methazolamide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0109	CcSEcCtD
Methazolamide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.0103	CcSEcCtD
Methazolamide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00177	0.01	CcSEcCtD
Methazolamide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.01	CcSEcCtD
Methazolamide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00937	CcSEcCtD
Methazolamide—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00906	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00828	CcSEcCtD
Methazolamide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.008	CcSEcCtD
Methazolamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.0079	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00785	CcSEcCtD
Methazolamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00783	CcSEcCtD
Methazolamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00749	CcSEcCtD
Methazolamide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00722	CcSEcCtD
Methazolamide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00708	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00702	CcSEcCtD
Methazolamide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00689	CcSEcCtD
Methazolamide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00689	CcSEcCtD
Methazolamide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00683	CcSEcCtD
Methazolamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.00652	CcSEcCtD
Methazolamide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00651	CcSEcCtD
Methazolamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00643	CcSEcCtD
Methazolamide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00628	CcSEcCtD
Methazolamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00622	CcSEcCtD
Methazolamide—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00606	CcSEcCtD
Methazolamide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00601	CcSEcCtD
Methazolamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00578	CcSEcCtD
Methazolamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00578	CcSEcCtD
Methazolamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00573	CcSEcCtD
Methazolamide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00572	CcSEcCtD
Methazolamide—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00571	CcSEcCtD
Methazolamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00569	CcSEcCtD
Methazolamide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000974	0.00553	CcSEcCtD
Methazolamide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000974	0.00553	CcSEcCtD
Methazolamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00095	0.0054	CcSEcCtD
Methazolamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000939	0.00533	CcSEcCtD
Methazolamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000927	0.00527	CcSEcCtD
Methazolamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00524	CcSEcCtD
Methazolamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00524	CcSEcCtD
Methazolamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00092	0.00523	CcSEcCtD
Methazolamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000903	0.00513	CcSEcCtD
Methazolamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000897	0.0051	CcSEcCtD
Methazolamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000897	0.0051	CcSEcCtD
Methazolamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000886	0.00503	CcSEcCtD
Methazolamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00495	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000869	0.00493	CcSEcCtD
Methazolamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000848	0.00481	CcSEcCtD
Methazolamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.00481	CcSEcCtD
Methazolamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000844	0.0048	CcSEcCtD
Methazolamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000844	0.00479	CcSEcCtD
Methazolamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000843	0.00479	CcSEcCtD
Methazolamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000837	0.00475	CcSEcCtD
Methazolamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000837	0.00475	CcSEcCtD
Methazolamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000812	0.00461	CcSEcCtD
Methazolamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000812	0.00461	CcSEcCtD
Methazolamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00454	CcSEcCtD
Methazolamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000795	0.00452	CcSEcCtD
Methazolamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00449	CcSEcCtD
Methazolamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000767	0.00435	CcSEcCtD
Methazolamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00415	CcSEcCtD
Methazolamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00073	0.00415	CcSEcCtD
Methazolamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000722	0.0041	CcSEcCtD
Methazolamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.0041	CcSEcCtD
Methazolamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00406	CcSEcCtD
Methazolamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00406	CcSEcCtD
Methazolamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000714	0.00406	CcSEcCtD
Methazolamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00402	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000701	0.00398	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000701	0.00398	CcSEcCtD
Methazolamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.0007	0.00398	CcSEcCtD
Methazolamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00398	CcSEcCtD
Methazolamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00398	CcSEcCtD
Methazolamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000688	0.00391	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000687	0.0039	CcSEcCtD
Methazolamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00389	CcSEcCtD
Methazolamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000682	0.00387	CcSEcCtD
Methazolamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.00385	CcSEcCtD
Methazolamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00383	CcSEcCtD
Methazolamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000673	0.00382	CcSEcCtD
Methazolamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00382	CcSEcCtD
Methazolamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000669	0.0038	CcSEcCtD
Methazolamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.0038	CcSEcCtD
Methazolamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000668	0.0038	CcSEcCtD
Methazolamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00379	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00376	CcSEcCtD
Methazolamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00375	CcSEcCtD
Methazolamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00366	CcSEcCtD
Methazolamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00366	CcSEcCtD
Methazolamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000642	0.00365	CcSEcCtD
Methazolamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000642	0.00365	CcSEcCtD
Methazolamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00064	0.00363	CcSEcCtD
Methazolamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.0036	CcSEcCtD
Methazolamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.0036	CcSEcCtD
Methazolamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000634	0.0036	CcSEcCtD
Methazolamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000632	0.00359	CcSEcCtD
Methazolamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00359	CcSEcCtD
Methazolamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00063	0.00358	CcSEcCtD
Methazolamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000629	0.00357	CcSEcCtD
Methazolamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00346	CcSEcCtD
Methazolamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00344	CcSEcCtD
Methazolamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000598	0.00339	CcSEcCtD
Methazolamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000583	0.00331	CcSEcCtD
Methazolamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000583	0.00331	CcSEcCtD
Methazolamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00324	CcSEcCtD
Methazolamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00316	CcSEcCtD
Methazolamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00316	CcSEcCtD
Methazolamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00312	CcSEcCtD
Methazolamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00309	CcSEcCtD
Methazolamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00298	CcSEcCtD
Methazolamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00293	CcSEcCtD
Methazolamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00293	CcSEcCtD
Methazolamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00291	CcSEcCtD
Methazolamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00291	CcSEcCtD
Methazolamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00291	CcSEcCtD
Methazolamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00291	CcSEcCtD
Methazolamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000509	0.00289	CcSEcCtD
Methazolamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000509	0.00289	CcSEcCtD
Methazolamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00287	CcSEcCtD
Methazolamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00285	CcSEcCtD
Methazolamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00285	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.00284	CcSEcCtD
Methazolamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00283	CcSEcCtD
Methazolamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00277	CcSEcCtD
Methazolamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.00276	CcSEcCtD
Methazolamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.00275	CcSEcCtD
Methazolamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00275	CcSEcCtD
Methazolamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00274	CcSEcCtD
Methazolamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00274	CcSEcCtD
Methazolamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00274	CcSEcCtD
Methazolamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00273	CcSEcCtD
Methazolamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000472	0.00268	CcSEcCtD
Methazolamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.00265	CcSEcCtD
Methazolamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00259	CcSEcCtD
Methazolamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.00257	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00044	0.0025	CcSEcCtD
Methazolamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00224	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00206	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00206	CcSEcCtD
Methazolamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00201	CcSEcCtD
Methazolamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000352	0.002	CcSEcCtD
Methazolamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00198	CcSEcCtD
Methazolamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00193	CcSEcCtD
Methazolamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00187	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00181	CcSEcCtD
Methazolamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00173	CcSEcCtD
Methazolamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00163	CcSEcCtD
Methazolamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000281	0.0016	CcSEcCtD
Methazolamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00158	CcSEcCtD
Methazolamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00157	CcSEcCtD
Methazolamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00157	CcSEcCtD
Methazolamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00156	CcSEcCtD
Methazolamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00156	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000263	0.0015	CcSEcCtD
Methazolamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00148	CcSEcCtD
Methazolamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00144	CcSEcCtD
Methazolamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00143	CcSEcCtD
Methazolamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0013	CcSEcCtD
Methazolamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00124	CcSEcCtD
Methazolamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00115	CcSEcCtD
Methazolamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00114	CcSEcCtD
Methazolamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00114	CcSEcCtD
Methazolamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00114	CcSEcCtD
Methazolamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00108	CcSEcCtD
Methazolamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000122	0.00194	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000121	0.00193	CbGpPWpGaD
Methazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.0019	CbGpPWpGaD
Methazolamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000118	0.00188	CbGpPWpGaD
Methazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00187	CbGpPWpGaD
Methazolamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00186	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000115	0.00184	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.000115	0.00183	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000114	0.00182	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00179	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00179	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000111	0.00177	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000111	0.00177	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00176	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.00174	CbGpPWpGaD
Methazolamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00171	CbGpPWpGaD
Methazolamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.0017	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000107	0.0017	CbGpPWpGaD
Methazolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00169	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000105	0.00167	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000105	0.00167	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000104	0.00166	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000104	0.00165	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000104	0.00165	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000102	0.00163	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000101	0.00162	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000101	0.00162	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000101	0.00162	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.71e-05	0.00155	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.64e-05	0.00154	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	9.6e-05	0.00153	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.58e-05	0.00153	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	9.46e-05	0.00151	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	9.46e-05	0.00151	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.43e-05	0.0015	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.34e-05	0.00149	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.33e-05	0.00149	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.33e-05	0.00149	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.32e-05	0.00149	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.24e-05	0.00147	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.21e-05	0.00147	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.08e-05	0.00145	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	9.05e-05	0.00144	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	8.76e-05	0.0014	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.71e-05	0.00139	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.71e-05	0.00139	CbGpPWpGaD
Methazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.64e-05	0.00138	CbGpPWpGaD
Methazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.53e-05	0.00136	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.52e-05	0.00136	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.46e-05	0.00135	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.4e-05	0.00134	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.34e-05	0.00133	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.07e-05	0.00129	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.02e-05	0.00128	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.99e-05	0.00127	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.91e-05	0.00126	CbGpPWpGaD
Methazolamide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.88e-05	0.00126	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.83e-05	0.00125	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.79e-05	0.00124	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.79e-05	0.00124	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.77e-05	0.00124	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.75e-05	0.00124	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.73e-05	0.00123	CbGpPWpGaD
Methazolamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.68e-05	0.00122	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.68e-05	0.00122	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.66e-05	0.00122	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.66e-05	0.00122	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.43e-05	0.00118	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	7.35e-05	0.00117	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.34e-05	0.00117	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.34e-05	0.00117	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.00116	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.00116	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.2e-05	0.00115	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.17e-05	0.00114	CbGpPWpGaD
Methazolamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.17e-05	0.00114	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.15e-05	0.00114	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.15e-05	0.00114	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.12e-05	0.00114	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.1e-05	0.00113	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.04e-05	0.00112	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.01e-05	0.00112	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7e-05	0.00112	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.99e-05	0.00111	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.96e-05	0.00111	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.78e-05	0.00108	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.78e-05	0.00108	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.73e-05	0.00107	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.7e-05	0.00107	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.00106	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.00106	CbGpPWpGaD
Methazolamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.64e-05	0.00106	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.57e-05	0.00105	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.53e-05	0.00104	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.53e-05	0.00104	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.48e-05	0.00103	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.48e-05	0.00103	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	6.45e-05	0.00103	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.44e-05	0.00103	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.44e-05	0.00103	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.44e-05	0.00103	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.42e-05	0.00102	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00102	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.33e-05	0.00101	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.33e-05	0.00101	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.26e-05	0.000998	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	6.19e-05	0.000987	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.000987	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.19e-05	0.000987	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.17e-05	0.000984	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.16e-05	0.000983	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.1e-05	0.000973	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.09e-05	0.000971	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6e-05	0.000957	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.95e-05	0.000949	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.92e-05	0.000944	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.92e-05	0.000944	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.000936	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.000935	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.69e-05	0.000907	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.65e-05	0.0009	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.0009	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.61e-05	0.000895	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.000887	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	5.55e-05	0.000885	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.48e-05	0.000874	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.37e-05	0.000856	CbGpPWpGaD
Methazolamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.3e-05	0.000844	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.2e-05	0.000829	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.15e-05	0.000821	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.12e-05	0.000817	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	5.08e-05	0.00081	CbGpPWpGaD
Methazolamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-05	0.00081	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.05e-05	0.000805	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.98e-05	0.000794	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.94e-05	0.000787	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.000787	CbGpPWpGaD
Methazolamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.87e-05	0.000776	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.73e-05	0.000754	CbGpPWpGaD
Methazolamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	4.73e-05	0.000754	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000746	CbGpPWpGaD
Methazolamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	4.61e-05	0.000735	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	4.61e-05	0.000735	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.58e-05	0.00073	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.54e-05	0.000724	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.54e-05	0.000723	CbGpPWpGaD
Methazolamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	4.53e-05	0.000722	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.000715	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.41e-05	0.000703	CbGpPWpGaD
Methazolamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.41e-05	0.000703	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.34e-05	0.000692	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	4.3e-05	0.000686	CbGpPWpGaD
Methazolamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	4.3e-05	0.000686	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.3e-05	0.000686	CbGpPWpGaD
Methazolamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.28e-05	0.000682	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.27e-05	0.000681	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.27e-05	0.000681	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.21e-05	0.000672	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	4.16e-05	0.000663	CbGpPWpGaD
Methazolamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-05	0.000656	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-05	0.000656	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.000636	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	3.99e-05	0.000636	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.93e-05	0.000626	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.87e-05	0.000617	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.87e-05	0.000616	CbGpPWpGaD
Methazolamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-05	0.000608	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000603	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.000593	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.67e-05	0.000585	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.55e-05	0.000566	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.3e-05	0.000526	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000525	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.000521	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.24e-05	0.000516	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.21e-05	0.000511	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	3.18e-05	0.000507	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-05	0.000486	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.04e-05	0.000485	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.03e-05	0.000484	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000479	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.99e-05	0.000477	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.98e-05	0.000475	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.000475	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.95e-05	0.00047	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.92e-05	0.000466	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	2.92e-05	0.000466	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-05	0.000465	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-05	0.000446	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.74e-05	0.000437	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000434	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-05	0.00041	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000392	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000379	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.27e-05	0.000362	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-05	0.000358	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000345	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-05	0.000327	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000316	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000308	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000301	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000286	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.000279	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.000276	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000258	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.61e-05	0.000257	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000255	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.59e-05	0.000254	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000252	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000252	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000251	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000248	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000235	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000232	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.45e-05	0.000232	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000231	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.00023	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000219	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.34e-05	0.000214	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000212	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000191	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000177	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.1e-05	0.000176	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000174	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000169	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000168	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000166	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000162	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.73e-06	0.000155	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000154	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.51e-06	0.000152	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	9.32e-06	0.000149	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.92e-06	0.000142	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.76e-06	0.00014	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.3e-06	0.000116	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.2e-06	0.000115	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.19e-06	0.000115	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.88e-06	0.00011	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.71e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.62e-06	0.000105	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	0.000105	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.36e-06	0.000101	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.33e-06	0.000101	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.27e-06	0.0001	CbGpPWpGaD
Methazolamide—CA7—trachea—chronic obstructive pulmonary disease	5.11e-06	0.109	CbGeAlD
Methazolamide—CA12—respiratory system—chronic obstructive pulmonary disease	4.49e-06	0.0955	CbGeAlD
Methazolamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.33e-06	6.9e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.14e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CA12—connective tissue—chronic obstructive pulmonary disease	3.96e-06	0.0841	CbGeAlD
Methazolamide—CA1—respiratory system—chronic obstructive pulmonary disease	3.56e-06	0.0757	CbGeAlD
Methazolamide—CA12—trachea—chronic obstructive pulmonary disease	3.32e-06	0.0706	CbGeAlD
Methazolamide—CA4—respiratory system—chronic obstructive pulmonary disease	2.78e-06	0.0591	CbGeAlD
Methazolamide—CA12—lung—chronic obstructive pulmonary disease	2.39e-06	0.0507	CbGeAlD
Methazolamide—CA2—respiratory system—chronic obstructive pulmonary disease	2.31e-06	0.049	CbGeAlD
Methazolamide—CA5B—lung—chronic obstructive pulmonary disease	2.14e-06	0.0455	CbGeAlD
Methazolamide—CA4—trachea—chronic obstructive pulmonary disease	2.06e-06	0.0437	CbGeAlD
Methazolamide—CA2—connective tissue—chronic obstructive pulmonary disease	2.03e-06	0.0432	CbGeAlD
Methazolamide—CA2—bronchus—chronic obstructive pulmonary disease	1.9e-06	0.0404	CbGeAlD
Methazolamide—CA1—lung—chronic obstructive pulmonary disease	1.89e-06	0.0402	CbGeAlD
Methazolamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	1.86e-06	0.0395	CbGeAlD
Methazolamide—CYP2E1—respiratory system—chronic obstructive pulmonary disease	1.85e-06	0.0393	CbGeAlD
Methazolamide—CA2—trachea—chronic obstructive pulmonary disease	1.7e-06	0.0362	CbGeAlD
Methazolamide—CA4—lung—chronic obstructive pulmonary disease	1.48e-06	0.0314	CbGeAlD
Methazolamide—CA2—lung—chronic obstructive pulmonary disease	1.23e-06	0.026	CbGeAlD
Methazolamide—CYP2E1—lung—chronic obstructive pulmonary disease	9.82e-07	0.0209	CbGeAlD
